ResearcherUniversity of ZurichNo recent work listed

Stephanie Tanadini‐Lang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4387-1522; OpenAlex author ID A5005687748. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper

Papers 1

Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer. Last author DOI 10.1186/s13014-017-0906-9 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Konstantina Karava · 1 shared paper, 2017 · strength 0.07
- Paper Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body … DOI 10.1186/s13014-017-0906-9 ↗
Matthias Gückenberger · 1 shared paper, 2017 · strength 0.07
- Paper Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body … DOI 10.1186/s13014-017-0906-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.